Health systems have made dozens of M&A deals this year, as many are seeking out partnerships to grow and protect their long-term financial sustainability. Here is a rundown of five newsworthy deals announced in 2023.
Last month at a conference, AdventHealth CEO Terry Shaw shared some employee retention strategies used at his health system. He stressed the importance of gathering employee feedback and using it to give them the changes they need. This month, MedCity News followed up with AdventHealth to get a better picture of what these strategies look like in practice.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
At a conference last week, AdventHealth CEO Terry Shaw discussed how his organization fosters a culture in which its workers feel heard and supported. Some of his advice included making necessary changes based on employee feedback and providing ample opportunities for career advancement.
M&A activity among health systems picked up last year — key trends included cross-market mega-mergers and academic medical centers expanding their community hospital networks. Despite tough economic conditions, Kaufman Hall experts expect this activity to continue growing in 2023.
The collaboration will build on AdventHealth's existing genomics and personalized health program, leveraging data to predict disease progression and response to treatments. Sema4's Centrellis data platform will be a core part of the new program.
Vaccine hesitancy is still a challenge to providers' immunization plans. Florida-based AdventHealth is bringing the might of AI technology — specifically machine learning and natural language processing — to combat the issue.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The health system and biotech company are collaborating to create a Covid-19 patient registry biobank, which will combine de-identified patient data and AI technology to identify characteristics and trends that have an impact on disease outcomes.
I’m not proud to say that in the past, I’ve played a role in cutting behavioral health programs in an effort to navigate budget constraints and mitigate financial losses. But my perspective as a finance executive is not what it used to be.